W
Wanli Bi
Researcher at Applied Biosystems
Publications - 6
Citations - 2726
Wanli Bi is an academic researcher from Applied Biosystems. The author has contributed to research in topics: Minimal residual disease & Leukemia. The author has an hindex of 6, co-authored 6 publications receiving 2625 citations.
Papers
More filters
Journal ArticleDOI
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
Jean Gabert,Emmanuel Beillard,V H J van der Velden,Wanli Bi,David Grimwade,Niels Pallisgaard,Gisela Barbany,Giovanni Cazzaniga,Jean Michel Cayuela,Hélène Cavé,Fabrizio Pane,J. L. E. Aerts,D De Micheli,X Thirion,V Pradel,Marcos González,Susanne Viehmann,Maria Malec,Giuseppe Saglio,J. J. M. Van Dongen +19 more
TL;DR: The development of standardized protocols for RQ-PCR analysis of FG transcripts provides a milestone for molecular determination of MRD levels and is likely to prove invaluable to the management of patients entered into multicenter therapeutic trials.
Journal ArticleDOI
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program
Emmanuel Beillard,Niels Pallisgaard,V H J van der Velden,Wanli Bi,R Dee,E van der Schoot,Eric Delabesse,E Macintyre,Enrico Gottardi,Giuseppe Saglio,F Watzinger,Thomas Lion,J. J. M. Van Dongen,Peter Hokland,Jean Gabert +14 more
TL;DR: The ABL gene is proposed to be used as CG for RQ-PCR-based diagnosis and MRD detection in leukemic patients and these data are not only eligible for quantifying of fusion gene transcripts, but also for the quantification of aberrantly expressed genes.
Journal ArticleDOI
Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay
G. Marcucci,Kenneth J. Livak,Wanli Bi,Matthew P. Strout,Clara D. Bloomfield,Michael A. Caligiuri +5 more
TL;DR: Real Time RT-PCR appears to offer advantages over previously used quantitative RT-pcR methods by providing absolute quantitation of the target sequence, expanding the dynamic range of quantitation to over six orders of magnitude, eliminating the post- PCR processing, and reducing labor and carryover contamination.
Journal ArticleDOI
Quantitative real-time RT-PCR analysis of PML-RARα mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129
Robert E. Gallagher,Beow Y. Yeap,Wanli Bi,Kenneth J. Livak,Nike Beaubier,Sreenivas V. Rao,Clara D. Bloomfield,Frederick R. Appelbaum,Martin S. Tallman,James L. Slack,Cheryl L. Willman +10 more
TL;DR: The potential prognostic value of quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR [qrtPCR]) measurements of PML-RAR alpha mRNA in acute promyelocytic leukemia was retrospectively assessed before treatment and at 3 posttreatment intervals in 123 patients on intergroup protocol 0129.
Patent
Polynucleotide sequence assay
TL;DR: In this paper, methods for detecting or quantifying one or more target polynucleotide sequences in a sample are presented. But none of the methods are presented for quantifying polynomial sequences.